As a microbiologist and infectious disease clinician, it has been tough to watch the recent devolution of public discourse on Covid-19 origins. It has been especially difficult for me to read the comments of Anthony Fauci about the origins debate in his now-public diary. And it has been painful to watch the televised spectacle hosted by the US senator Rand Paul on 29 July involving a hostile interrogation of Fauci. Despite many early pleas, including my own, for a dispassionate, objective assessment of what we know, don’t know and need…
Tag: Medical research
Anthony Fauci’s diaries take aim at News Corp journalist Sharri Markson’s ‘nonsense’ Covid-19 investigation
Dr Anthony Fauci, the US’s chief medical adviser at the start of the pandemic, has described a book by News Corp investigative journalist Sharri Markson backing the “lab leak” theory of Covid-19’s origins as a “bunch of nonsense” in his newly released diaries. This week, Fauci, 85, was subpoenaed by the Republican senator Rand Paul to appear at a Senate hearing into Covid-19 and his handling of the pandemic. The physician and veteran former director of the National Institute of Allergy and Infectious Diseases, who retired in 2022, accused Paul…
UK Biobank has my data, but I’m not worried. I know the benefits are too great to consider pulling out | Polly Toynbee
One thing Britain is exceptionally good at is collecting and using health data for research, studying cohorts of people over many decades. A shudder of alarm rippled through the research world at the news this week that UK Biobank’s data had been put up for sale on China’s Alibaba site, with the science minister, Patrick Vallance, saying that more attempts to sell the data in China were expected. Some sensationalised reporting failed to make clear enough that no names, addresses, NHS numbers or other identifiers were included, nor that the…
Menstrual blood test could offer alternative to cervical screening for cancer
A pioneering test of period blood for signs of cervical cancer could be a convenient, non-invasive and accurate way of screening for the disease, researchers have said. A regular sanitary pad topped with a blood sample strip can pick up human papillomavirus (HPV), which causes most cases of cervical cancer, and could be used by women at home, the results of a study indicate. Currently, most women undergo cervical screening under the care of a clinician, who collects a sample via a brush inserted into the vagina. But millions of…
The Guardian view on Merck’s exit: Britain’s biopharma strategy stalls in the face of China’s rise | Editorial
The industry’s retreat from the UK reflects a deeper shift about how Beijing is rewriting the rules of innovation When Merck abruptly scrapped its billion-pound London research hub last week, critics blamed Britain’s lacklustre support for life sciences and a Scrooge-like grip on NHS drug prices. But one important factor may have been missed. That Merck, which is also cutting jobs elsewhere – 6,000 globally – is recalibrating not just in response to the UK or the US, but to China. Merck’s cash cow is pembrolizumab (brand name Keytruda), an…
Brainless bodies and pig organs: does science back up Putin and Xi’s longevity claims?
Perhaps it was the extravagant display of deadly weaponry that prompted Xi Jinping and Vladimir Putin to mull on mortality at this week’s military parade in Beijing. It was more banter than serious discussion, but with both aged 72, the Chinese president and his Russian counterpart may feel the cold hand on the shoulder more than Kim Jong-un, the 41-year-old North Korean leader who strolled beside them. Speaking through a interpreter, Xi told Putin that 70 is considered young today, prompting Putin to claim that human organs can now be…
Healthy living, science and an army of doctors: Putin’s pursuit of longevity
It was the stuff of Bond villains. Two ageing autocrats, their younger ally in tow, ambled down a red-carpeted ramp before a military parade in Beijing when a hot mic picked up a question that seemed to be on their minds: how long could they keep going – and, between the lines, might science allow them to rule for ever? With advances in technology, Russia’s Vladimir Putin assured Xi Jinping via his translator that “human organs can be constantly transplanted, to the extent that people can get younger, perhaps even…
Swarms of tiny nose robots could clear infected sinuses, researchers say
Swarms of tiny robots, each no larger than a speck of dust, could be deployed to cure stubborn infected sinuses before being blown out through the nose into a tissue, researchers have claimed. The micro-robots are a fraction of the width of a human hair and have been inserted successfully into animal sinuses in pre-clinical trials by researchers at universities in China and Hong Kong. Swarms are injected into the sinus cavity via a duct threaded through the nostril and guided to their target by electromagnetism, where they can be…
New daily weight-loss pill shows success at clinical trial
A significant trial of a daily weight-loss pill has found that it helped people to shed the pounds and reduce their blood sugar levels, making it a contender to join the new wave of drugs that combat obesity and diabetes. People who took a 36mg pill of orforglipron lost an average of 7.3kg (16lbs) over nine months, according to results from a phase 3 clinical trial reported by the drug’s manufacturer, Eli Lilly, on Thursday. The trial, which enrolled 559 obese people with type 2 diabetes from the US, China,…
AstraZeneca buys Chinese cancer therapy firm Gracell for $1.2bn
AstraZeneca has struck a deal to buy a Chinese cancer therapy company for up to $1.2bn (£950m), as Britain’s biggest drugmaker expands its footprint in its second-largest market. The Anglo-Swedish pharmaceutical firm announced on Tuesday it would acquire Gracell Biotechnologies, which is focused on a type of cancer therapy known as CAR-T that modifies a patient’s cells to fight the disease. The deal marks a further investment in cancer research and treatment, which accounts for about one-third of AstraZeneca’s business, as well as its continued push to expand in China.…